This report comes with 10% free customization, enabling you to add data that meets your specific business needs.
The global precision cardiology market is projected to reach $3,584.6 million by 2031 from $956.6 million in 2020, at a CAGR of 12.90% during the forecast period 2021-2031.
Market Report Coverage - Precision Cardiology
Market Segmentation
- Offering - Product and Service
- Sample - Blood and Non-Blood
- Technology - Sequencing, Polymerase Chain Reaction (PCR), Microarray, and Other Technologies
- Application - Cardiomyopathy, Arrhythmia, Aortopathy and Vascular Diseases, Familial Hypercholesterolemia (FH), Congenital Heart Defects and Syndromes, and Other Applications
- End User - Hospitals and Diagnostic Laboratories, Academic and Research Institutes, and Other End Users
Regional Segmentation
- North America - U.S., and Canada
- Europe - Germany, France, U.K., Italy, Spain, Switzerland, and Rest-of-Europe
- Asia-Pacific - China, India, Japan, South Korea, Australia, and Rest-of-Asia-Pacific
- Latin America - Brazil, Mexico, and Rest-of-Latin America
- Rest-of-the-World
Market Growth Drivers
- Rising Burden of Cardiovascular Diseases
- Increasing Focus on Early Cardiovascular Disease (CVD) Screening
- Decreasing Cost of Sequencing
Market Challenges
- Lack of Established Regulatory Policies in the Precision Cardiology Ecosystem
- Lack of High Complexity Testing Centers
- Existing Diagnostic Confidence on Conventional Cardiovascular Disease (CVD) Tests
Market Opportunities
- Massive Scope for Adoption of NGS-Based Cardiology Tests in Emerging Markets
Key Companies Profiled
ARUP Laboratories, CENTOGENE N.V., Eurofins Scientific, Exact Sciences Corporation, Fulgent Genetics, Inc., Illumina, Inc., Invitae Corporation, Konica Minolta, Inc., Laboratory Corporation of America Holdings, OPKO Health, Inc., OraSure Technologies, Inc., PerkinElmer Inc., Quest Diagnostics Incorporated, Sema4 OpCo, Inc., Thermo Fisher Scientific Inc., GENinCode, Devyser Diagnostics AB
Key Questions Answered in the Report
- How is precision cardiology revolutionizing the field of cardiovascular care?
- What are the major market drivers, challenges, and opportunities in the global precision cardiology market?
- What are the underlying structures resulting in the emerging trends within the global precision cardiology market?
- How did the COVID-19 pandemic impact the global precision cardiology ecosystem?
- What are the key development strategies that are being implemented by the major players in order to sustain themselves in the competitive market?
- What are the key regulatory implications in developed and developing regions pertaining to the use of precision cardiology products and services?
- What are the potential entry barriers, which are expected to be faced by the companies willing to enter a particular region?
- How is each segment of the market expected to grow during the forecast period 2021-2031, and what is the anticipated revenue to be generated by each of the segments?
- What are the growth opportunities for the companies in the region of their operation?
- Who are the leading players with significant offerings in the global precision cardiology market?
- Which companies are anticipated to be highly disruptive in the future, and why?
Market Overview
Our healthcare experts have found the precision cardiology industry to be one of the most rapidly evolving and dynamic markets and the global market for precision cardiology is predicted to grow at a CAGR of 12.90% over the forecast period of 2021-2031. The market is driven by certain factors, which includes the rising burden of cardiovascular diseases, increasing focus on early cardiovascular disease screening, and decreasing cost of sequencing.
Currently, the precision cardiology industry is witnessing an upsurge due to the rising burden of cardiovascular diseases, increasing focus on early cardiovascular disease screening, and decreasing cost of sequencing. Furthermore, companies are focusing on the development of precision cardiology tests based on advanced sequencing technologies, which is expected to further support physicians to offer better informed clinical decisions in the field of cardiovascular care. The development of advanced precision cardiology tests also enables the research community to establish effective strategies for the discovery of novel genetic biomarkers associated with cardiovascular diseases, which could be harnessed to develop novel therapies.
Within the research report, the market is segmented on the basis of service, sample, technology, application, end users, and region. Each of these segments covers the snapshot of the market over the projected years, the inclination of the market revenue, underlying patterns, and trends by using analytics on the primary and secondary data obtained.
Competitive Landscape
The exponential rise in the incidence associated with cardiovascular diseases, worldwide has created a buzz among the biotechnology companies to further invest in the development of precision cardiology tests based on sequencing technologies for supporting physicians to offer precision care in the field of cardiology. Due to the expansive service portfolio and massive geographical presence, Laboratory Corporation of America Holdings has been the leading player in the precision cardiology ecosystem.
On the basis of region, North America holds the largest share of the precision cardiology market due to the presence of market leaders such as Laboratory Corporation of America Holdings, Illumina, Inc., PerkinElmer Inc., Thermo Fisher Scientific Inc., and Quest Diagnostics Incorporated in the U.S. coupled with the significant adoption of high-fidelity precision cardiology tests for diagnosing cardiovascular diseases. Further, rising fund infusions by the federal organizations coupled with increasing investments for precision cardiology test development, are some of the prominent underlying factors supporting the growth of the North America precision cardiology market. Apart from this, the Asia-Pacific region is anticipated to grow at the fastest CAGR during the forecast period, 2021-2031. This is majorly attributed to the underlying factors such as the rising incidence of cardiovascular diseases, increase in healthcare awareness, steady economy leading to higher focus on research, and growing adoption of precision cardiology tests, among others.
Table of Contents
1 Market
1.1 Product Definition
1.1.1 Inclusion and Exclusion
1.2 Market Scope
1.2.1 Key Questions Answered in the Report
1.3 Research Methodology
1.3.1 Global Precision Cardiology Market: Research Methodology
1.3.2 Data Sources
1.3.2.1 Primary Data Sources
1.3.2.2 Secondary Data Sources
1.3.3 Market Estimation Model
1.3.4 Criteria for Company Profiling
1.4 Market Overview
1.4.1 Market Definition
1.4.2 Market Footprint and Growth Potential, $Million, 2020-2031
1.4.3 Future Potential
1.4.4 Impact of COVID-19 on the Global Precision Cardiology Market
2 Competitive Landscape
2.1 Overview
2.2 Synergistic Activities
2.3 Product Launches
2.4 Product Approvals
2.5 Business Expansion
2.6 Market Share Analysis, 2019-2020
2.7 Growth-Share Analysis
2.7.1 Growth-Share Analysis (by Company)
2.7.2 Growth-Share Analysis (by Technology)
2.7.3 Growth-Share Analysis (by Application)
3 Industry Analysis
3.1 Overview
3.2 Legal Requirements and Framework in the U.S.
3.2.1 FDA Regulation
3.2.2 CMS Regulation
3.3 Legal Requirements and Framework in Europe
3.4 Legal Requirements and Framework in Asia-Pacific
3.4.1 China
3.4.2 Japan
3.4.3 South Korea
3.4.4 Australia
4 Market Dynamics
4.1 Overview
4.2 Iceberg Analysis of the Global Precision Cardiology Market
4.3 Impact Analysis
4.4 Market Drivers
4.4.1 Rising Burden of Cardiovascular Diseases
4.4.2 Increasing Focus on Early Cardiovascular Disease (CVD) Screening
4.4.3 Decreasing Cost of Sequencing
4.5 Market Restraints
4.5.1 Lack of Established Regulatory Policies in the Precision Cardiology Ecosystem
4.5.2 Lack of High Complexity Testing Centers
4.5.3 Existing Diagnostic Confidence on Conventional Cardiovascular Disease (CVD) Tests
4.6 Market Opportunities
4.6.1 Massive Scope for Adoption of NGS-Based Cardiology Tests in Emerging Markets
5 Global Precision Cardiology Market, by Offering, $Million, 2020 - 2031
5.1 Overview
5.2 Service
5.3 Product
6 Global Precision Cardiology Market, by Sample, $Million, 2020 - 2031
6.1 Overview
6.2 Blood
6.3 Non-Blood
6.3.1 Saliva
6.3.2 Buccal Swabs
6.3.3 Other Non-Blood Samples
7 Global Precision Cardiology Market, by Technology, $Million, 2020 – 2031
7.1 Overview
7.2 Sequencing
7.2.1 Next-Generation Sequencing (NGS)
7.2.2 Sanger Sequencing
7.3 Polymerase Chain Reaction (PCR)
7.4 Microarray
7.5 Other Technologies
8 Global Precision Cardiology Market, by Application, $Million, 2020 - 2031
8.1 Overview
8.2 Cardiomyopathy
8.2.1 Global Precision Cardiology Market for Cardiomyopathy (by Technology)
8.3 Arrhythmia
8.3.1 Global Precision Cardiology Market for Arrhythmia (by Technology)
8.4 Aortopathy and Vascular Diseases
8.4.1 Global Precision Cardiology Market for Aortopathy and Vascular Diseases (by Technology)
8.5 Familial Hypercholesterolemia (FH)
8.5.1 Global Precision Cardiology Market for Familial Hypercholesterolemia (FH) (by Technology)
8.6 Congenital Heart Defects and Syndromes
8.6.1 Global Precision Cardiology Market for Congenital Heart Defects and Syndromes (by Technology)
8.7 Other Applications
9 Global Precision Cardiology Market, by End User, $Million, 2020-2031
9.1 Overview
9.2 Hospitals and Diagnostic Laboratories
9.3 Academic and Research Institutes
9.4 Other End Users
10 Global Precision Cardiology Market, by Region, $Million, 2020-2031
10.1 Overview
10.2 North America
10.2.1 U.S.
10.2.2 Canada
10.3 Europe
10.3.1 Germany
10.3.2 France
10.3.3 U.K.
10.3.4 Italy
10.3.5 Spain
10.3.6 Switzerland
10.3.7 Rest-of-Europe
10.4 Asia-Pacific
10.4.1 China
10.4.2 India
10.4.3 Japan
10.4.4 South Korea
10.4.5 Australia
10.4.6 Rest-of-Asia-Pacific
10.5 Latin America
10.5.1 Brazil
10.5.2 Mexico
10.5.3 Rest-of-Latin America
10.6 Rest-of-the-World
11 Company Profiles
11.1 Overview
11.2 Market Value Chain of Precision Cardiology
11.3 ARUP Laboratories
11.3.1 Company Overview
11.3.2 Role of ARUP Laboratories in the Global Precision Cardiology Market
11.3.3 Key Customers of the Company
11.3.4 Key Competitors of the Company
11.3.5 SWOT Analysis
11.4 CENTOGENE N.V.
11.4.1 Company Overview
11.4.2 Role of CENTOGENE N.V. in the Global Precision Cardiology Market
11.4.3 Key Customers of the Company
11.4.4 Key Competitors of the Company
11.4.5 Financials
11.4.6 Key Insights About Financial Health of the Company
11.4.7 Corporate Strategies
11.4.7.1 Synergistic Activities
11.4.8 SWOT Analysis
11.5 Eurofins Scientific
11.5.1 Company Overview
11.5.2 Role of Eurofins Scientific in the Global Precision Cardiology Market
11.5.3 Key Competitors of the Company
11.5.4 Financials
11.5.5 SWOT Analysis
11.6 Exact Sciences Corporation
11.6.1 Company Overview
11.6.2 Role of Exact Sciences Corporation in the Global Precision Cardiology Market
11.6.3 Key Customers of the Company
11.6.4 Key Competitors of the Company
11.6.5 Financials
11.6.6 Key Insights about Financial Health of the Company
11.6.7 Corporate Strategies
11.6.7.1 Acquisition
11.6.8 SWOT Analysis
11.7 Fulgent Genetics, Inc.
11.7.1 Company Overview
11.7.2 Role of Fulgent Genetics, Inc. in the Global Precision Cardiology Market
11.7.3 Key Customers of the Company
11.7.4 Key Competitors of the Company
11.7.5 Financials
11.7.6 Key Insights About Financial Health of the Company
11.7.7 Business Strategies
11.7.7.1 Service Approval
11.7.8 SWOT Analysis
11.8 Illumina, Inc.
11.8.1 Company Overview
11.8.2 Role of Illumina, Inc. in the Global Precision Cardiology Market
11.8.3 Key Customers of the Company
11.8.4 Key Competitors of the Company
11.8.5 Financials
11.8.6 Key Insights About Financial Health of the Company
11.8.7 SWOT Analysis
11.9 Invitae Corporation
11.9.1 Company Overview
11.9.2 Role of Invitae Corporation in the Global Precision Cardiology Market
11.9.3 Key Customers of the Company
11.9.4 Key Competitors of the Company
11.9.5 Financials
11.9.6 Key Insights About Financial Health of the Company
11.9.7 Corporate Strategies
11.9.7.1 Synergistic Activities
11.9.8 SWOT Analysis
11.1 Konica Minolta, Inc.
11.10.1 Company Overview
11.10.2 Role of Konica Minolta, Inc. in the Global Precision Cardiology Market
11.10.3 Key Customers of the Company
11.10.4 Key Competitors of the Company
11.10.5 Financials
11.10.6 Key Insights About Financial Health of the Company
11.10.7 Corporate Strategies
11.10.7.1 Synergistic Activities
11.10.8 SWOT Analysis
11.11 Laboratory Corporation of America Holdings
11.11.1 Company Overview
11.11.2 Role of Laboratory Corporation of America Holdings in the Global Precision Cardiology Market
11.11.3 Key Customers of the Company
11.11.4 Key Competitors of the Company
11.11.5 Financials
11.11.6 Corporate Strategies
11.11.6.1 Synergistic Activities
11.11.7 Business Strategies
11.11.7.1 Product Launch
11.11.8 SWOT Analysis
11.12 OPKO Health, Inc.
11.12.1 Company Overview
11.12.2 Role of OPKO Health, Inc. in the Global Precision Cardiology Market
11.12.3 Key Customers of the Company
11.12.4 Key Competitors of the Company
11.12.5 Financials
11.12.2 Key Insights About Financial Health of the Company
11.12.3 SWOT Analysis
11.13 OraSure Technologies, Inc.
11.13.1 Company Overview
11.13.2 Role of OraSure Technologies, Inc. in the Global Precision Cardiology Market
11.13.3 Key Customers of the Company
11.13.4 Financials
11.13.5 Key Insights About Financial Health of the Company
11.13.6 Business Strategies
11.13.6.1 Product Approvals
11.13.7 SWOT Analysis
11.14 PerkinElmer Inc.
11.14.1 Company Overview
11.14.2 Role of PerkinElmer Inc. in the Global Precision Cardiology Market
11.14.3 Key Customers of the Company
11.14.4 Key Competitors of the Company
11.14.5 Financials
11.14.6 Key Insights About Financial Health of the Company
11.14.7 Corporate Strategies
11.14.7.1 Business Expansion
11.14.8 SWOT Analysis
11.15 Quest Diagnostics Incorporated
11.15.1 Company Overview
11.15.2 Role of Quest Diagnostics Incorporated in the Global Precision Cardiology Market
11.15.3 Key Customers of the Company
11.15.4 Key Competitors of the Company
11.15.5 Financials
11.15.6 Business Strategies
11.15.6.1 Product Launch
11.15.7 SWOT Analysis
11.16 Sema4 OpCo, Inc.
11.16.1 Company Overview
11.16.2 Role of Sema4 OpCo, Inc. in the Global Precision Cardiology Market
11.16.3 Key Customers of the Company
11.16.4 Key Competitors of the Company
11.16.5 Corporate Strategies
11.16.5.1 Synergistic Activities
11.16.6 SWOT Analysis
11.17 Thermo Fisher Scientific Inc.
11.17.1 Company Overview
11.17.2 Role of Thermo Fisher Scientific Inc. in the Global Precision Cardiology Market
11.17.3 Key Customers of the Company
11.17.4 Key Competitors of the Company
11.17.5 Financials
11.17.6 Key Insights About Financial Health of the Company
11.17.7 SWOT Analysis
11.18 Global Precision Cardiology Market: Emerging Companies
11.18.1 GENinCode
11.18.1.1 Company Overview
11.18.1.2 Role of GENinCode in the Global Precision Cardiology Market
11.18.1.3 Key Customers of the Company
11.18.1.4 Key Competitors of the Company
11.18.1.5 Corporate Strategies
11.18.1.5.1 Synergistic Activities
11.18.1.6 Business Strategies
11.18.1.6.1 Product Approval
11.18.1.7 SWOT Analysis
11.18.2 Devyser Diagnostics AB
11.18.2.1 Company Overview
11.18.2.2 Role of Devyser Diagnostics AB in the Global Precision Cardiology Market
11.18.2.3 Key Customers of the Company
11.18.2.4 Key Competitors of the Company
11.18.2.5 Financials
11.18.2.6 SWOT Analysis
List of Figures
Figure 1: Global Incidence of Cardiovascular Diseases, 2015-2019
Figure 2: Impact Analysis of Market Drivers and Market Challenges on the Global Precision Cardiology Market
Figure 3: Global Precision Cardiology Market (by Offering), $Million, 2020 and 2031
Figure 4: Global Precision Cardiology Market (by Sample), $Million, 2020 and 2031
Figure 5: Global Precision Cardiology Market (by Technology), $Million, 2020 and 2031
Figure 6: Global Precision Cardiology Market (by Application), $Million, 2020 and 2031
Figure 7: Global Precision Cardiology Market (by End User), $Million, 2020 and 2031
Figure 8: Global Precision Cardiology Market Snapshot (by Region)
Figure 9: Global Precision Cardiology Market Segmentation
Figure 10: Global Precision Cardiology Market: Research Methodology
Figure 11: Primary Research Methodology
Figure 12: Bottom-Up Approach (Segment-Wise Analysis)
Figure 13: Top-Down Approach (Segment-Wise Analysis)
Figure 14: Global Precision Cardiology Market, $Million, 2020-2031
Figure 15: Global Precision Cardiology Market: COVID-19 Impact Analysis
Figure 16: Share of Key Developments and Strategies, January 2018-January 2022
Figure 17: Share of Synergistic Activities (by Company), January 2018-January 2022
Figure 18: Number of Product Launches (by Company), January 2018-January 2022
Figure 19: Share of Product Approvals (by Company), January 2018-January 2022
Figure 20: Share of Business Expansion (by Company), January 2018-January 2022
Figure 21: Market Share Analysis for Global Precision Cardiology Market, $Million, 2019 and 2020
Figure 22: Growth-Share Analysis for Global Precision Cardiology Market (by Company), 2020
Figure 23: Growth-Share Analysis for Global Precision Cardiology Market (by Technology), 2020-2031
Figure 24: Growth-Share Analysis for Global Precision Cardiology Market (by Application), 2020-2031
Figure 25: FDA Classification and Regulatory Process
Figure 26: Key Changes in EU IVD Regulation 2017/746
Figure 27: Europe’s IVD Regulatory Approval Process
Figure 28: Medical Device Regulatory Approval Process in China
Figure 29: Medical Device Regulatory Approval Process in South Korea
Figure 30: Classification of IVD Devices
Figure 31: Medical Device (IVDs) Regulatory Approval Process in Australia
Figure 32: Iceberg Analysis of the Global Precision Cardiology Market
Figure 33: Global Incidence of Cardiovascular Diseases, 2015-2019
Figure 34: Decreasing Cost and Increasing Output (Terabyte (TB)) of Genome Sequencing, 2009-2025
Figure 35: Global Precision Cardiology Market (by Offering)
Figure 36: Global Precision Cardiology Market (by Offering), $Million, 2020 and 2031
Figure 37: Global Precision Cardiology Market (Service), $Million, 2020-2031
Figure 38: Global Precision Cardiology Market (Product), $Million, 2020-2031
Figure 39: Global Precision Cardiology Market (by Sample)
Figure 40: Global Precision Cardiology Market (by Sample), $Million, 2020 and 2031
Figure 41: Global Precision Cardiology Market (Blood), $Million, 2020-2031
Figure 42: Global Precision Cardiology Market (Non-Blood), $Million, 2020-2031
Figure 43: Global Precision Cardiology Market (by Non-Blood), $Million, 2020 and 2031
Figure 44: Global Precision Cardiology Market (Saliva), $Million, 2020-2031
Figure 45: Global Precision Cardiology Market (Buccal Swabs), $Million, 2020-2031
Figure 46: Global Precision Cardiology Market (Other Non-Blood Samples), $Million, 2020-2031
Figure 47: Global Precision Cardiology Market (by Technology)
Figure 48: Global Precision Cardiology Market (by Technology), $Million, 2020 and 2031
Figure 49: Global Precision Cardiology Market (Sequencing), $Million, 2020-2031
Figure 50: Global Precision Cardiology Market (by Sequencing), $Million, 2020 and 2031
Figure 51: Global Precision Cardiology Market (Next-Generation Sequencing (NGS)), $Million, 2020-2031
Figure 52: Global Precision Cardiology Market (Sanger Sequencing), $Million, 2020-2031
Figure 53: Global Precision Cardiology Market (Polymerase Chain Reaction (PCR)), $Million, 2020-2031
Figure 54: Global Precision Cardiology Market (Microarray), $Million, 2020-2031
Figure 55: Global Precision Cardiology Market (Other Technologies), $Million, 2020-2031
Figure 56: Global Precision Cardiology Market (by Application)
Figure 57: Global Precision Cardiology Market (by Application), $Million, 2020-2031
Figure 58: Global Precision Cardiology Market (Cardiomyopathy), $Million, 2020-2031
Figure 59: Growth-Share Analysis for Global Precision Cardiology Market for Cardiomyopathy (by Technology), 2020-2031
Figure 60: Global Precision Cardiology Market (Arrhythmia), $Million, 2020-2031
Figure 61: Growth-Share Analysis for Global Precision Cardiology Market for Arrhythmia (by Technology), 2020-2031
Figure 62: Global Precision Cardiology Market (Aortopathy and Vascular Diseases), $Million, 2020-2031
Figure 63: Growth-Share Analysis for Global Precision Cardiology Market for Aortopathy and Vascular Diseases (by Technology), 2020-2031
Figure 64: Global Precision Cardiology Market (Familial Hypercholesterolemia (FH)), $Million, 2020-2031
Figure 65: Growth-Share Analysis for Global Precision Cardiology Market for Familial Hypercholesterolemia (FH) (by Technology), 2020-2031
Figure 66: Global Precision Cardiology Market (Congenital Heart Defects and Syndromes), $Million, 2020-2031
Figure 67: Growth-Share Analysis for Global Precision Cardiology Market for Congenital Heart Defects and Syndromes (by Technology), 2020-2031
Figure 68: Global Precision Cardiology Market (Other Applications), $Million, 2020-2031
Figure 69: Global Precision Cardiology Market (by End User)
Figure 70: Global Precision Cardiology Market (by End User), $Million, 2020–2031
Figure 71: Global Precision Cardiology Market (Hospitals and Diagnostic Laboratories), $Million, 2020-2031
Figure 72: Global Precision Cardiology Market (Academic and Research Institutes), $Million, 2020-2031
Figure 73: Global Precision Cardiology Market (Other End Users), $Million, 2020-2031
Figure 74: Global Precision Cardiology Market Snapshot (by Region)
Figure 75: Global Precision Cardiology Market (by Region), $Million, 2020-2031
Figure 76: Global Precision Cardiology Market (by Region), 2020 and 2031
Figure 77: North America Precision Cardiology Market, $Million, 2020-2031
Figure 78: North America Precision Cardiology Market (by Country), $Million, 2020-2031
Figure 79: U.S. Precision Cardiology Market, $Million, 2020-2031
Figure 80: Canada Precision Cardiology Market, $Million, 2020-2031
Figure 81: Europe Precision Cardiology Market, $Million, 2020-2031
Figure 82: Europe Precision Cardiology Market (by Country), $Million, 2020–2031
Figure 83: Germany Precision Cardiology Market, $Million, 2020-2031
Figure 84: France Precision Cardiology Market, $Million, 2020-2031
Figure 85: U.K. Precision Cardiology Market, $Million, 2020-2031
Figure 86: Italy Precision Cardiology Market, $Million, 2020-2031
Figure 87: Spain Precision Cardiology Market, $Million, 2020-2031
Figure 88: Switzerland Precision Cardiology Market, $Million, 2020-2031
Figure 89: Rest-of-Europe Precision Cardiology Market, $Million, 2020-2031
Figure 90: Asia-Pacific Precision Cardiology Market, $Million, 2020-2031
Figure 91: Asia-Pacific Precision Cardiology Market (by Country), $Million, 2020-2031
Figure 92: China Precision Cardiology Market, $Million, 2020-2031
Figure 93: India Precision Cardiology Market, $Million, 2020-2031
Figure 94: Japan Precision Cardiology Market, $Million, 2020-2031
Figure 95: South Korea Precision Cardiology Market, $Million, 2020-2031
Figure 96: Australia Precision Cardiology Market, $Million, 2020-2031
Figure 97: Rest-of-Asia-Pacific Precision Cardiology Market, $Million, 2020-2031
Figure 98: Latin America Precision Cardiology Market, $Million, 2020-2031
Figure 99: Latin America Precision Cardiology Market (by Country), $Million, 2020-2031
Figure 100: Brazil Precision Cardiology Market, $Million, 2020-2031
Figure 101: Mexico Precision Cardiology Market, $Million, 2020-2031
Figure 102: Rest-of-Latin America Precision Cardiology Market, $Million, 2020-2031
Figure 103: Rest-of-the-World Precision Cardiology Market, $Million, 2020-2031
Figure 104: Total Number of Companies Profiled
Figure 105: Global Precision Cardiology Market: Value Chain
Figure 106: ARUP Laboratories: Service Portfolio
Figure 107: ARUP Laboratories: SWOT Analysis
Figure 108: CENTOGENE N.V.: Service Portfolio
Figure 109: CENTOGENE N.V.: Overall Financials, $Million, 2018-2020
Figure 110: CENTOGENE N.V.: Revenue (by Business Segment), $Million, 2018–2020
Figure 111: CENTOGENE N.V.: Revenue (by Region), $Million, 2018-2020
Figure 112: CENTOGENE N.V.: R&D Expenditure, $Million, 2018-2020
Figure 113: CENTOGENE N.V.: SWOT Analysis
Figure 114: Eurofins Scientific: Service Portfolio
Figure 115: Eurofins Scientific: Overall Financials, $Million, 2018-2020
Figure 116: Eurofins Scientific: Revenue (by Region), $Million, 2018-2020
Figure 117: Eurofins Scientific: SWOT Analysis
Figure 118: Exact Sciences Corporation: Service Portfolio
Figure 119: Exact Sciences Corporation: Overall Financials, $Million, 2018-2020
Figure 120: Exact Sciences Corporation: Revenue (by Business Segment), $Million, 2018-2020
Figure 121: Exact Sciences Corporation: Revenue (by Region), $Million, 2018-2020
Figure 122: Exact Sciences Corporation: R&D Expenditure, $Million, 2018-2020
Figure 123: Exact Sciences Corporation: SWOT Analysis
Figure 124: Fulgent Genetics, Inc.: Service Portfolio
Figure 125: Fulgent Genetics, Inc.: Overall Financials, $Million, 2018-2020
Figure 126: Fulgent Genetics, Inc.: Revenue (by Region), $Million, 2018-2020
Figure 127: Fulgent Genetics, Inc.: R&D Expenditure, $Million, 2018-2020
Figure 128: Fulgent Genetics, Inc.: SWOT Analysis
Figure 129: Illumina, Inc.: Product Portfolio
Figure 130: Illumina, Inc.: Overall Financials, $Million, 2018-2020
Figure 131: Illumina, Inc.: Revenue (by Business Segment), $Million, 2018–2020
Figure 132: Illumina, Inc.: Revenue (by Region), $Million, 2018–2020
Figure 133: Illumina, Inc.: R&D Expenditure, $Million, 2018-2020
Figure 134: Illumina, Inc.: SWOT Analysis
Figure 135: Invitae Corporation: Service Portfolio
Figure 136: Invitae Corporation: Overall Financials, $Million, 2018-2020
Figure 137: Invitae Corporation: Revenue (by Business Segment), $Million, 2018–2020
Figure 138: Invitae Corporation: Revenue (by Region), $Million, 2018-2020
Figure 139: Invitae Corporation: R&D Expenditure, $Million, 2018-2020
Figure 140: Invitae Corporation: SWOT Analysis
Figure 141: Konica Minolta, Inc.: Service Portfolio
Figure 142: Konica Minolta, Inc.: Overall Financials, $Million, 2018-2020
Figure 143: Konica Minolta, Inc.: Revenue (by Business Segment), $Million, 2019–2020
Figure 144: Konica Minolta, Inc.: Revenue (by Healthcare Business), $Million, 2019–2020
Figure 145: Konica Minolta, Inc.: Revenue (by Region), $Million, 2018-2020
Figure 146: Konica Minolta, Inc.: R&D Expenditure, $Million, 2018-2020
Figure 147: Konica Minolta, Inc.: SWOT Analysis
Figure 148: Laboratory Corporation of America Holdings: Service Portfolio
Figure 149: Laboratory Corporation of America Holdings: Overall Financials, $Million, 2018-2020
Figure 150: Laboratory Corporation of America Holdings: Revenue (by Business Segment), $Million, 2018-2020
Figure 151: Laboratory Corporation of America Holdings: Revenue (by Region), $Million, 2018-2020
Figure 152: Laboratory Corporation of America Holdings: SWOT Analysis
Figure 153: OPKO Health, Inc.: Service Portfolio
Figure 154: OPKO Health, Inc.: Overall Financials, $Million, 2018-2020
Figure 155: OPKO Health, Inc.: Revenue (by Business Segment), $Million, 2018–2020
Figure 156: OPKO Health, Inc.: Revenue (by Region), $Million, 2018-2020
Figure 157: OPKO Health, Inc.: R&D Expenditure, $Million, 2018-2020
Figure 158: OPKO Health: SWOT Analysis
Figure 159: OraSure Technologies, Inc.: Product Portfolio
Figure 160: OraSure Technologies, Inc.: Overall Financials, $Million, 2018-2020
Figure 161: OraSure Technologies, Inc.: Revenue (by Business Segment), $Million, 2018-2020
Figure 162: OraSure Technologies, Inc.: Revenue (by Molecular Solutions), $Million, 2019-2020
Figure 163: OraSure Technologies, Inc.: Revenue (by Region), $Million, 2018-2020
Figure 164: OraSure Technologies, Inc.: R&D Expenditure, $Million, 2018-2020
Figure 165: OraSure Technologies, Inc.: SWOT Analysis
Figure 166: PerkinElmer Inc.: Service and Product Portfolio
Figure 167: PerkinElmer Inc.: Overall Financials, $Million, 2018-2020
Figure 168: PerkinElmer Inc.: Revenue (by Business Segment), $Million, 2018-2020
Figure 169: PerkinElmer Inc.: Revenue (by Region), $Million, 2018-2020
Figure 170: PerkinElmer Inc.: R&D Expenditure, $Million, 2018-2020
Figure 171: PerkinElmer Inc.: SWOT Analysis
Figure 172: Quest Diagnostics Incorporated: Service Portfolio
Figure 173: Quest Diagnostics Incorporated: Overall Financials, $Million, 2018-2020
Figure 174: Quest Diagnostics Incorporated: Revenue (by Business Segment), $Million, 2018-2020
Figure 175: Quest Diagnostics Incorporated: SWOT Analysis
Figure 176: Sema4 OpCo, Inc.: Service Portfolio
Figure 177: Sema4 OpCo, Inc.: SWOT Analysis
Figure 178: Thermo Fisher Scientific Inc.: Product Portfolio
Figure 179: Thermo Fisher Scientific Inc.: Overall Financials, $Million, 2018-2020
Figure 180: Thermo Fisher Scientific Inc.: Revenue (by Business Segment), $Million, 2018–2020
Figure 181: Thermo Fisher Scientific Inc.: Revenue (by Region), $Million, 2018–2020
Figure 182: Thermo Fisher Scientific Inc.: R&D Expenditure, $Million, 2018-2020
Figure 183: Thermo Fisher Scientific Inc.: SWOT Analysis
Figure 184: GENinCode: Product Portfolio
Figure 185: GENinCode: SWOT Analysis
Figure 186: Devyser Diagnostics AB: Product Portfolio
Figure 187: Devyser Diagnostics AB: Overall Financials, $Million, 2018-2020
Figure 188: Devyser Diagnostics AB: SWOT Analysis
List of Tables
Table 1: Likert Scale
Table 2: Impact Analysis of Market Drivers
Table 3: Impact Analysis of Market Restraints
Table 4: Precision Cardiology Services Offered by Key Players
Table 5: Precision Cardiology Products Offered by Key Manufacturers
Table 6: Precision Cardiology Tests for Cardiomyopathy
Table 7: Precision Cardiology Tests for Arrhythmia
Table 8: Precision Cardiology Tests for Aortopathy and Vascular Diseases
Table 9: Precision Cardiology Tests for Familial Hypercholesterolemia (FH)
Table 10: Precision Cardiology Tests for Congenital Heart Defects and Syndromes
Table 11: Precision Cardiology Tests for Other Applications
Table 12: North America: Market Dynamics
Table 13: Europe: Market Dynamics
Table 14: Asia-Pacific: Market Dynamics
Table 15: Latin America: Market Dynamics
Samples
LOADING...
Companies Mentioned
- ARUP Laboratories
- CENTOGENE N.V.
- Eurofins Scientific
- Exact Sciences Corporation
- Fulgent Genetics, Inc.
- Illumina, Inc.
- Invitae Corporation
- Konica Minolta, Inc.
- Laboratory Corporation of America Holdings
- OPKO Health, Inc.
- OraSure Technologies, Inc.
- PerkinElmer Inc.
- Quest Diagnostics Incorporated
- Sema4 OpCo, Inc.
- Thermo Fisher Scientific Inc.
- GENinCode
- Devyser Diagnostics AB
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 242 |
| Published | February 2022 |
| Forecast Period | 2021 - 2031 |
| Estimated Market Value ( USD | $ 1065.6 Million |
| Forecasted Market Value ( USD | $ 3584.6 Million |
| Compound Annual Growth Rate | 12.9% |
| Regions Covered | Global |
| No. of Companies Mentioned | 17 |
